Your browser doesn't support javascript.
loading
Blue toe syndrome, severe haemophilia A and emicizumab.
Cardoso, Patrícia Santos Resende; da Silva, Camila Beatriz Pereira Gomes; de Abreu, Eliabe Silva; Oliveira, Andrea Gonçalves; Pereira, Isabel Figueiredo de Magalhães; Navarro, Túlio Pinho; Rezende, Suely Meireles.
Affiliation
  • Cardoso PSR; Hematology and Oncology Unit, University Hospital, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • da Silva CBPG; Hematology, HEMOMINAS Foundation, Belo Horizonte, Minas Gerais, Brazil.
  • de Abreu ES; Haemostasis and Thrombosis Study Group, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Oliveira AG; Haemostasis and Thrombosis Study Group, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Pereira IFM; Hematology, HEMOMINAS Foundation, Belo Horizonte, Minas Gerais, Brazil.
  • Navarro TP; Vascular Surgery, University Hospital, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Rezende SM; Department of Surgery, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Haemophilia ; 30(1): 241-244, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37870891

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Blue Toe Syndrome / Hemophilia A Limits: Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2024 Type: Article Affiliation country: Brazil

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Blue Toe Syndrome / Hemophilia A Limits: Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2024 Type: Article Affiliation country: Brazil